Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2018
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- 03 Oct 2018 Planned End Date changed from 13 Nov 2018 to 20 Dec 2018.
- 03 Oct 2018 Planned primary completion date changed from 13 Nov 2018 to 20 Dec 2018.
- 03 Oct 2018 Status changed from recruiting to active, no longer recruiting.